RT Journal Article
SR Electronic
T1 <sup>18</sup>F-FDG PET/CT Imaging Features of Cardiac Arrhythmia in a Patient Treated with Panitumumab
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP 360
OP 361
DO 10.2967/jnmt.121.262216
VO 49
IS 4
A1 Pokhraj P. Suthar
A1 Jagadeesh S. Singh
A1 Khushboo Gupta
YR 2021
UL http://tech.snmjournals.org/content/49/4/360.abstract
AB Panitumumab is a new humanized antiepidermal growth factor receptor monoclonal antibody (mAb) approved for the treatment of advanced colorectal cancer. There is an increase in the use of this drug due to a good response rate and possible secondary resection in advanced colorectal cancer. Here, we present 18F-FDG PET/CT imaging findings of cardiac arrhythmia in a patient receiving panitumumab for the treatment of metastatic infiltrating rectal adenocarcinoma. Cardiotoxicity is a known adverse effect associated with panitumumab. So far, to our knowledge, no documented imaging findings for the same are available in the literature.